Literature DB >> 15733548

Sensitization to morphine withdrawal in guinea-pigs.

Akiko Mizutani1, Jenny Arvidsson, Loris A Chahl.   

Abstract

The aim of this study was to determine whether sensitization occurred to morphine withdrawal. Guinea-pigs were treated twice daily with increasing doses of morphine (10-100 mg/kg s.c.) for 3 days followed by injection of morphine 100 mg/kg on the fourth day. Sixty min after the last morphine injection, animals were withdrawn from morphine with naltrexone, 15 mg/kg s.c., and locomotor activity and all other behaviours scored over 90 min. Animals were then rested for 3 days. This procedure was repeated twice over the next 2 weeks. Control animals were treated with saline for the first two treatment cycles. Guinea-pigs subjected to three cycles of morphine withdrawal showed a significant increase in the total number of withdrawal behaviour counts over the 90-min observation period following the third cycle of withdrawal compared with the first and second withdrawal cycles. However, locomotor activity, a major sign of morphine withdrawal in guinea-pigs, was not significantly increased. Fos-LI was markedly increased in the repeatedly withdrawn animals in several brain regions, including amygdala, dorsal striatum, thalamus, ventral tegmental area, and ventrolateral periaqueductal gray area. It is concluded that sensitization to morphine withdrawal occurs in guinea-pigs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733548     DOI: 10.1016/j.ejphar.2004.12.043

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  1 in total

1.  The adenosinergic system is involved in sensitization to morphine withdrawal signs in rats-neurochemical and molecular basis in dopaminergic system.

Authors:  Joanna Listos; Irena Baranowska-Bosiacka; Agnieszka Wąsik; Sylwia Talarek; Maciej Tarnowski; Piotr Listos; Małgorzata Łupina; Lucyna Antkiewicz-Michaluk; Izabela Gutowska; Marta Tkacz; Anna Pilutin; Jolanta Orzelska-Górka; Dariusz Chlubek; Sylwia Fidecka
Journal:  Psychopharmacology (Berl)       Date:  2016-04-18       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.